ID   UBP1_HUMAN              Reviewed;         785 AA.
AC   O94782; A0PJ95; D3DQ57; Q05BX7; Q59H66; Q9UFR0; Q9UNJ3;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   15-MAR-2017, entry version 155.
DE   RecName: Full=Ubiquitin carboxyl-terminal hydrolase 1;
DE            EC=3.4.19.12 {ECO:0000269|PubMed:15694335, ECO:0000269|PubMed:16531995, ECO:0000269|PubMed:18082604, ECO:0000269|PubMed:26388029, ECO:0000269|PubMed:9806842};
DE   AltName: Full=Deubiquitinating enzyme 1;
DE            Short=hUBP;
DE   AltName: Full=Ubiquitin thioesterase 1;
DE   AltName: Full=Ubiquitin-specific-processing protease 1;
GN   Name=USP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CATALYTIC ACTIVITY.
RC   TISSUE=Fetal brain;
RX   PubMed=9806842; DOI=10.1006/geno.1998.5554;
RA   Fjiwara T., Saito A., Suzuki M., Shinomiya H., Suzuki T.,
RA   Takahashi E., Tanigami A., Ichiyama A., Chung C.H., Nakamura Y.,
RA   Tanaka K.;
RT   "Identification and chromosomal assignment of USP1, a novel gene
RT   encoding a human ubiquitin-specific protease.";
RL   Genomics 54:155-158(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Seibold S., Marx M.;
RT   "Molecular cloning of a novel human ubiquitin-specific protease.";
RL   Submitted (JAN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye, Testis, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, DEVELOPMENTAL STAGE, UBIQUITINATION,
RP   INTERACTION WITH FANCD2, MUTAGENESIS OF CYS-90, CATALYTIC ACTIVITY,
RP   AND ACTIVE SITE.
RX   PubMed=15694335; DOI=10.1016/j.molcel.2005.01.008;
RA   Nijman S.M.B., Huang T.T., Dirac A.M.G., Brummelkamp T.R.,
RA   Kerkhoven R.M., D'Andrea A.D., Bernards R.;
RT   "The deubiquitinating enzyme USP1 regulates the Fanconi Anemia
RT   pathway.";
RL   Mol. Cell 17:331-339(2005).
RN   [8]
RP   FUNCTION, CLEAVAGE SITE, MUTAGENESIS OF CYS-90 AND 670-GLY-GLY-671,
RP   CATALYTIC ACTIVITY, AND ACTIVE SITE.
RX   PubMed=16531995; DOI=10.1038/ncb1378;
RA   Huang T.T., Nijman S.M.B., Mirchandani K.D., Galardy P.J., Cohn M.A.,
RA   Haas W., Gygi S.P., Ploegh H.L., Bernards R., D'Andrea A.D.;
RT   "Regulation of monoubiquitinated PCNA by DUB autocleavage.";
RL   Nat. Cell Biol. 8:339-347(2006).
RN   [9]
RP   CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, FUNCTION,
RP   INTERACTION WITH WDR48, AND INDUCTION.
RX   PubMed=18082604; DOI=10.1016/j.molcel.2007.09.031;
RA   Cohn M.A., Kowal P., Yang K., Haas W., Huang T.T., Gygi S.P.,
RA   D'Andrea A.D.;
RT   "A UAF1-containing multisubunit protein complex regulates the Fanconi
RT   anemia pathway.";
RL   Mol. Cell 28:786-797(2007).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-42, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-67, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-42, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-475, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16; SER-42; SER-67;
RP   SER-313 AND SER-475, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   FUNCTION, CATALYTIC ACTIVITY, INTERACTION WITH WDR48, MUTAGENESIS OF
RP   CYS-90 AND GLU-444, AND ACTIVE SITE.
RX   PubMed=26388029; DOI=10.1016/j.str.2015.08.010;
RA   Yin J., Schoeffler A.J., Wickliffe K., Newton K., Starovasnik M.A.,
RA   Dueber E.C., Harris S.F.;
RT   "Structural insights into WD-repeat 48 activation of ubiquitin-
RT   specific protease 46.";
RL   Structure 23:2043-2054(2015).
CC   -!- FUNCTION: Negative regulator of DNA damage repair which
CC       specifically deubiquitinates monoubiquitinated FANCD2
CC       (PubMed:15694335). Also involved in PCNA-mediated translesion
CC       synthesis (TLS) by deubiquitinating monoubiquitinated PCNA
CC       (PubMed:16531995). Has almost no deubiquitinating activity by
CC       itself and requires the interaction with WDR48 to have a high
CC       activity (PubMed:18082604, PubMed:26388029).
CC       {ECO:0000269|PubMed:15694335, ECO:0000269|PubMed:16531995,
CC       ECO:0000269|PubMed:18082604, ECO:0000269|PubMed:26388029}.
CC   -!- CATALYTIC ACTIVITY: Thiol-dependent hydrolysis of ester,
CC       thioester, amide, peptide and isopeptide bonds formed by the C-
CC       terminal Gly of ubiquitin (a 76-residue protein attached to
CC       proteins as an intracellular targeting signal).
CC       {ECO:0000269|PubMed:15694335, ECO:0000269|PubMed:16531995,
CC       ECO:0000269|PubMed:18082604, ECO:0000269|PubMed:26388029,
CC       ECO:0000269|PubMed:9806842}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.7 uM for ubiquitin vinyl sulfone (in presence of WDR48)
CC         {ECO:0000269|PubMed:18082604};
CC         KM=1.4 uM for ubiquitin vinyl sulfone (in absence of WDR48)
CC         {ECO:0000269|PubMed:18082604};
CC   -!- SUBUNIT: Interacts with FANCD2 and PCNA (PubMed:15694335,
CC       PubMed:16531995). Interacts with WDR48 (PubMed:18082604,
CC       PubMed:26388029). {ECO:0000269|PubMed:15694335,
CC       ECO:0000269|PubMed:16531995, ECO:0000269|PubMed:18082604,
CC       ECO:0000269|PubMed:26388029}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15694335}.
CC   -!- DEVELOPMENTAL STAGE: Cell cycle-regulated. Highest level during S
CC       phase. {ECO:0000269|PubMed:15694335}.
CC   -!- INDUCTION: Down-regulated following DNA damage.
CC       {ECO:0000269|PubMed:18082604}.
CC   -!- PTM: Autocatalytic cleavage of USP1 following UV irradiation
CC       inactivates it leading to an increase in ubiquitinated PCNA,
CC       recruitment of POLH and translesion synthesis.
CC       {ECO:0000269|PubMed:15694335, ECO:0000269|PubMed:16531995}.
CC   -!- PTM: Ubiquitinated; leading to its subsequent proteasomal
CC       degradation. {ECO:0000250}.
CC   -!- MISCELLANEOUS: HEK293T cells expressing reduced levels of USP1
CC       show a higher level of ubiquitinated PCNA and an increase in point
CC       mutations upon UV irradiation.
CC   -!- SIMILARITY: Belongs to the peptidase C19 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH18745.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=AAH32364.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=BAD92130.1; Type=Frameshift; Positions=230; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB014458; BAA34703.1; -; mRNA.
DR   EMBL; AF117386; AAD11441.1; -; mRNA.
DR   EMBL; AL117575; CAB55999.1; -; mRNA.
DR   EMBL; AL117503; CAB55967.1; -; mRNA.
DR   EMBL; AB208893; BAD92130.1; ALT_FRAME; mRNA.
DR   EMBL; CH471059; EAX06585.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX06586.1; -; Genomic_DNA.
DR   EMBL; BC050525; AAH50525.1; -; mRNA.
DR   EMBL; BC018745; AAH18745.1; ALT_SEQ; mRNA.
DR   EMBL; BC032364; AAH32364.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS621.1; -.
DR   PIR; T17309; T17309.
DR   RefSeq; NP_001017415.1; NM_001017415.1.
DR   RefSeq; NP_001017416.1; NM_001017416.1.
DR   RefSeq; NP_003359.3; NM_003368.4.
DR   UniGene; Hs.35086; -.
DR   ProteinModelPortal; O94782; -.
DR   SMR; O94782; -.
DR   BioGrid; 113241; 57.
DR   DIP; DIP-53609N; -.
DR   IntAct; O94782; 34.
DR   MINT; MINT-4719170; -.
DR   STRING; 9606.ENSP00000343526; -.
DR   BindingDB; O94782; -.
DR   ChEMBL; CHEMBL1795087; -.
DR   GuidetoPHARMACOLOGY; 2428; -.
DR   MEROPS; C19.019; -.
DR   iPTMnet; O94782; -.
DR   PhosphoSitePlus; O94782; -.
DR   BioMuta; USP1; -.
DR   OGP; O94782; -.
DR   EPD; O94782; -.
DR   MaxQB; O94782; -.
DR   PaxDb; O94782; -.
DR   PeptideAtlas; O94782; -.
DR   PRIDE; O94782; -.
DR   DNASU; 7398; -.
DR   Ensembl; ENST00000339950; ENSP00000343526; ENSG00000162607.
DR   Ensembl; ENST00000371146; ENSP00000360188; ENSG00000162607.
DR   GeneID; 7398; -.
DR   KEGG; hsa:7398; -.
DR   UCSC; uc001daj.3; human.
DR   CTD; 7398; -.
DR   DisGeNET; 7398; -.
DR   GeneCards; USP1; -.
DR   H-InvDB; HIX0159950; -.
DR   HGNC; HGNC:12607; USP1.
DR   HPA; HPA028387; -.
DR   HPA; HPA028440; -.
DR   MIM; 603478; gene.
DR   neXtProt; NX_O94782; -.
DR   OpenTargets; ENSG00000162607; -.
DR   PharmGKB; PA37233; -.
DR   eggNOG; KOG1864; Eukaryota.
DR   eggNOG; ENOG410XQ81; LUCA.
DR   GeneTree; ENSGT00850000132276; -.
DR   HOVERGEN; HBG017288; -.
DR   InParanoid; O94782; -.
DR   KO; K11832; -.
DR   OMA; EYRASEI; -.
DR   OrthoDB; EOG091G04D9; -.
DR   PhylomeDB; O94782; -.
DR   TreeFam; TF331057; -.
DR   Reactome; R-HSA-110314; Recognition of DNA damage by PCNA-containing replication complex.
DR   Reactome; R-HSA-6783310; Fanconi Anemia Pathway.
DR   ChiTaRS; USP1; human.
DR   GeneWiki; USP1; -.
DR   GenomeRNAi; 7398; -.
DR   PRO; PR:O94782; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000162607; -.
DR   CleanEx; HS_USP1; -.
DR   ExpressionAtlas; O94782; baseline and differential.
DR   Genevisible; O94782; HS.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; TAS:ProtInc.
DR   GO; GO:0008233; F:peptidase activity; EXP:Reactome.
DR   GO; GO:0004843; F:thiol-dependent ubiquitin-specific protease activity; IDA:UniProtKB.
DR   GO; GO:0042769; P:DNA damage response, detection of DNA damage; TAS:Reactome.
DR   GO; GO:0036297; P:interstrand cross-link repair; TAS:Reactome.
DR   GO; GO:0035520; P:monoubiquitinated protein deubiquitination; IMP:UniProtKB.
DR   GO; GO:0016579; P:protein deubiquitination; IDA:UniProtKB.
DR   GO; GO:0006282; P:regulation of DNA repair; IDA:UniProtKB.
DR   GO; GO:0009411; P:response to UV; IDA:UniProtKB.
DR   GO; GO:0001501; P:skeletal system development; IEA:Ensembl.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro.
DR   CDD; cd02671; Peptidase_C19O; 1.
DR   InterPro; IPR001394; Peptidase_C19_UCH.
DR   InterPro; IPR033815; USP1.
DR   InterPro; IPR018200; USP_CS.
DR   InterPro; IPR028889; USP_dom.
DR   Pfam; PF00443; UCH; 1.
DR   PROSITE; PS00972; USP_1; 1.
DR   PROSITE; PS00973; USP_2; 1.
DR   PROSITE; PS50235; USP_3; 1.
PE   1: Evidence at protein level;
KW   Autocatalytic cleavage; Complete proteome; DNA damage; DNA repair;
KW   Hydrolase; Nucleus; Phosphoprotein; Protease; Reference proteome;
KW   Thiol protease; Ubl conjugation; Ubl conjugation pathway.
FT   CHAIN         1    785       Ubiquitin carboxyl-terminal hydrolase 1.
FT                                /FTId=PRO_0000080615.
FT   DOMAIN       81    785       USP.
FT   ACT_SITE     90     90       Nucleophile.
FT                                {ECO:0000269|PubMed:15694335,
FT                                ECO:0000269|PubMed:16531995,
FT                                ECO:0000269|PubMed:26388029}.
FT   ACT_SITE    593    593       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10092, ECO:0000255|PROSITE-
FT                                ProRule:PRU10093}.
FT   SITE        671    672       Cleavage; by autolysis.
FT                                {ECO:0000269|PubMed:16531995}.
FT   MOD_RES      16     16       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      42     42       Phosphoserine.
FT                                {ECO:0000244|PubMed:17525332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      67     67       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     313    313       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     475    475       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     768    768       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8BJQ2}.
FT   MUTAGEN      90     90       C->S: Loss of catalytic activity
FT                                including autolysis.
FT                                {ECO:0000269|PubMed:15694335,
FT                                ECO:0000269|PubMed:16531995,
FT                                ECO:0000269|PubMed:26388029}.
FT   MUTAGEN     444    444       E->K: Strongly reduces interaction with
FT                                WDR48 and activation by WDR48.
FT                                {ECO:0000269|PubMed:26388029}.
FT   MUTAGEN     670    671       GG->AA: Loss of autolysis-mediated
FT                                degradation upon UV irradiation. No
FT                                effect on catalytic activity.
FT                                {ECO:0000269|PubMed:16531995}.
FT   CONFLICT    621    621       I -> M (in Ref. 2; AAD11441).
FT                                {ECO:0000305}.
SQ   SEQUENCE   785 AA;  88207 MW;  50AA2817A60810AF CRC64;
     MPGVIPSESN GLSRGSPSKK NRLSLKFFQK KETKRALDFT DSQENEEKAS EYRASEIDQV
     VPAAQSSPIN CEKRENLLPF VGLNNLGNTC YLNSILQVLY FCPGFKSGVK HLFNIISRKK
     EALKDEANQK DKGNCKEDSL ASYELICSLQ SLIISVEQLQ ASFLLNPEKY TDELATQPRR
     LLNTLRELNP MYEGYLQHDA QEVLQCILGN IQETCQLLKK EEVKNVAELP TKVEEIPHPK
     EEMNGINSIE MDSMRHSEDF KEKLPKGNGK RKSDTEFGNM KKKVKLSKEH QSLEENQRQT
     RSKRKATSDT LESPPKIIPK YISENESPRP SQKKSRVKIN WLKSATKQPS ILSKFCSLGK
     ITTNQGVKGQ SKENECDPEE DLGKCESDNT TNGCGLESPG NTVTPVNVNE VKPINKGEEQ
     IGFELVEKLF QGQLVLRTRC LECESLTERR EDFQDISVPV QEDELSKVEE SSEISPEPKT
     EMKTLRWAIS QFASVERIVG EDKYFCENCH HYTEAERSLL FDKMPEVITI HLKCFAASGL
     EFDCYGGGLS KINTPLLTPL KLSLEEWSTK PTNDSYGLFA VVMHSGITIS SGHYTASVKV
     TDLNSLELDK GNFVVDQMCE IGKPEPLNEE EARGVVENYN DEEVSIRVGG NTQPSKVLNK
     KNVEAIGLLG GQKSKADYEL YNKASNPDKV ASTAFAENRN SETSDTTGTH ESDRNKESSD
     QTGINISGFE NKISYVVQSL KEYEGKWLLF DDSEVKVTEE KDFLNSLSPS TSPTSTPYLL
     FYKKL
//
